Coffey Steven R. S. — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Coffey Steven R. S. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Steven R. S. Coffey is a corporate director who, based on the most recent SEC filing dated 2026-07-08, serves as a director of Kazia Therapeutics Ltd, an Australian biotechnology company listed on the ASX. The available SEC filing identifies him by name in a director role but does not provide a detailed public biography. He participates in board governance for Kazia, contributing to oversight of strategy and corporate affairs. Additional biographical details may be available from company disclosures, press releases, or regulatory filings, but are not included in the referenced filing.
Steven R. S. Coffey is a corporate director who, based on the most recent SEC filing dated 2026-07-08, serves as a director of Kazia Therapeutics Ltd, an Australian biotechnology company listed on the ASX. The available SEC filing identifies him by name in a director role but does not provide a detailed public biography. He participates in board governance for Kazia, contributi…
How many SEC Form 4 filings has Coffey Steven R. S. submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Coffey Steven R. S.'s SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
